furazolidone has been researched along with Onchocerciasis in 1 studies
Furazolidone: A nitrofuran derivative with antiprotozoal and antibacterial activity. Furazolidone acts by gradual inhibition of monoamine oxidase. (From Martindale, The Extra Pharmacopoeia, 30th ed, p514)
furazolidone : A member of the class of oxazolidines that is 1,3-oxazolidin-2-one in which the hydrogen attached to the nitrogen is replaced by an N-{[(5-nitro-2-furyl)methylene]amino} group. It has antibacterial and antiprotozoal properties, and is used in the treatment of giardiasis and cholera.
Onchocerciasis: Infection with nematodes of the genus ONCHOCERCA. Characteristics include the presence of firm subcutaneous nodules filled with adult worms, PRURITUS, and ocular lesions.
Excerpt | Relevance | Reference |
---|---|---|
"12 adult onchocerciasis patients from the rain forest zone of Nigeria were treated with furazolidone in divided daily doses ranging from 5--15 mg per kg body weight for 7--21 days to a maximum total dose of 6." | 7.66 | Failure of furazolidone in the treatment of onchocerciasis. ( Kale, OO, 1981) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kale, OO | 1 |
1 other study available for furazolidone and Onchocerciasis
Article | Year |
---|---|
Failure of furazolidone in the treatment of onchocerciasis.
Topics: Adolescent; Adult; Animals; Female; Furazolidone; Humans; Male; Microfilariae; Middle Aged; Nigeria; | 1981 |